StonvexLoading…
StonvexStonvexStonvexCore line items from CACI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $8.63B | $7.66B | $6.70B | $6.20B |
Operating Income | $764.18M | $649.71M | $567.50M | $496.33M |
Net Income | $499.83M | $419.92M | $384.74M | $366.79M |
EPS (Diluted) | $22.32 | $18.60 | $16.43 | $15.49 |
Total Assets | $8.65B | $6.80B | $6.60B | $6.63B |
Total Liabilities | $4.75B | $3.28B | $3.38B | $3.58B |
Cash & Equivalents | $106.18M | $133.96M | $115.78M | $114.80M |
Free Cash Flow OCF − CapEx | $481.41M | $433.64M | $324.34M | $670.99M |
Shares Outstanding | 21.99M | 22.30M | 22.80M | 23.42M |